🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study seeks to evaluate the effect of intepirdine (RVT-101) on gait an...
Status
Completed
Location
US101
Start Date
2016-10
Trial ID
NCT02910102
Treatments Being Tested
This 6-month extension study will provide further information regarding the...
Status
Terminated
Location
US138
Start Date
2016-10
Trial ID
NCT02928445
Treatments Being Tested
The study is designed to investigate the efficacy, safety and tolerability ...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-07-04
Trial ID
NCT00708552
The purpose of this study is to find out if SB-742457 is a safe treatment a...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-05
Trial ID
NCT00348192
SB-742457 is a 5HT6 receptor antagonist that is in development for the symp...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-08
Trial ID
NCT00551772
Treatments Being Tested
The purpose of this study is to find out if SB-742457 is a safe treatment a...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-09
Trial ID
NCT00224497
Treatments Being Tested
The study is designed to investigate the safety and efficacy of SB-742457 w...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-07-01
Trial ID
NCT00710684
Treatments Being Tested
This 12-month open-label study will provide further information regarding t...
Status
Terminated
Location
US112
Start Date
2016-04-26
Trial ID
NCT02586909
Treatments Being Tested
This study seeks to evaluate the efficacy and safety of intepirdine (RVT-10...
Status
Completed
Location
US138
Start Date
2016-01
Trial ID
NCT02669433
Treatments Being Tested
This study seeks to confirm a demonstrated treatment effect of intepirdine ...
Status
Completed
Location
US112
Start Date
2015-10
Trial ID
NCT02585934